By the XLV/SPY ratio and several other indicators, risk is back on in the markets VIX: Deeply depressed from the hysterical April high, indicating complacency High Yield (junk) Spreads: Deeply…
The XLV/SPY ratio is a potential risk-off signal, and it is turning back down When Healthcare (XLV) rises vs. the broad market (SPY) it is a risk-off signal. Hence, we…
Rosenberg recommends defensive positioning amid dis-inflationary, recessionary pressure The NFTRH theme has been disinflation and economic signals fading toward counter-cyclical. Check. Everybody's got the memo now. Even the tardy Fed…
Good cop (QQQ/SPY ratio) is holding the bull flag and turning up. I assume the happy stuff out of Microsoft is boosting spirits. Reference the original Good/Bad cop update. In…
Defensive sectors Healthcare, Staples and Utilities are relatively strong this week Got to love those machines, always programmed for literal logic. But what happens when the rotation to more defensive…
...it's a market in trouble. This is a disgusting daily chart of the Healthcare sector ETF, XLV. Especially when you consider that the ratio of said defensive sector is firmly…
Back on April 21st NFTRH 548 noted that the medical device babies were getting thrown out with the politically hyped bathwater that was submerging the Healthcare sector. I finally took…
On May 22 this post reviewed... What Healthcare Needs to Do to Go Bullish In that post we reviewed the XLV/SPY ratio, noting the hard 'V' bounce, which has since…
It's been a hard road for this more defensive sector since the casino bottomed out at the Christmas Eve Massacre and its patrons gradually regained their backbones in order to…
We have been noting that Tech, for example, is 100% intact to its daily, weekly and monthly up trends. As I hold a big chunk of QQQ off of the…
Semi Sector Let's begin at the beginning, with our Semi Equipment indicators. Again, for the many folks who were not with us in January of 2013, we recall that month…
The Healthcare sector, under pains of congressional follies in trying to hammer out anything in revision to Obamacare, is not responding well. Since our last look, XLV has maintained its…
A look at the general Healthcare ETF (XLV), which includes BioPharma, Devices/Equipment and Services shows it easing below the trend line. IHI is at lateral support and the SMA 50…
Back in April of this year we did an NFTRH+ on BioPharma ABBV and its amazingly similar setup to 2016's NFTRH+ pick, LRCX. The original target was noted as 84,…